Atorvastatin significantly attenuated ischemia-induced overexpression of HMGB1, RAGE, TLR4, and NF-κB, significantly improving neurological deficits and reducing cerebral edema and infarct size 24 h after stroke [184]. The gene discussed is HMGB1; the disease is stroke disorder.